mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.24 |
2e-05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.22 |
4e-05 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |